Follow
Andrew T. Jones
Andrew T. Jones
Verified email at rockefeller.edu
Title
Cited by
Cited by
Year
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
R Yamin, AT Jones, HH Hoffmann, A Schäfer, KS Kao, RL Francis, ...
Nature 599 (7885), 465-470, 2021
1302021
HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge
AT Jones, X Shen, KL Walter, CC LaBranche, LS Wyatt, GD Tomaras, ...
Nature communications 10 (1), 798, 2019
692019
Oral immunization with a recombinant Lactococcus lactis–expressing HIV-1 antigen on group A Streptococcus pilus induces strong mucosal immunity in the gut
V Chamcha, A Jones, BR Quigley, JR Scott, RR Amara
The Journal of Immunology 195 (10), 5025-5034, 2015
522015
A trimeric HIV-1 envelope gp120 immunogen induces potent and broad anti-V1V2 loop antibodies against HIV-1 in rabbits and rhesus macaques
AT Jones, V Chamcha, S Kesavardhana, X Shen, D Beaumont, R Das, ...
Journal of Virology 92 (5), 10.1128/jvi. 01796-17, 2018
342018
Functional MAIT cells are associated with reduced simian–human immunodeficiency virus infection
A Murugesan, C Ibegbu, TM Styles, AT Jones, U Shanmugasundaram, ...
Frontiers in immunology 10, 3053, 2020
162020
A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques
A Sahoo, AT Jones, N Cheedarla, S Gangadhara, V Roy, TM Styles, ...
Science immunology 7 (73), eabl4102, 2022
82022
The system can't perform the operation now. Try again later.
Articles 1–6